JM

Juan-Pablo Mas

Partner at Action Potential VC | @SomosVC | opinions my own

San Francisco Bay Area

Investor
VC

Invests in

Stages:

Series B

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Venture Capital
Product Management
Start-ups
Medical Devices
Entrepreneurship
Cross-functional Team Leadership
Product Development
Business Development
Mergers
R&D
Product Marketing
Business Strategy
Mergers & Acquisitions
Corporate Development
Marketing Strategy
Private Equity
Strategic Partnerships
Lifesciences
Financial Modeling
Management

Education

Investments

Presidio Medical

Series A

Total Funding: $100M

Saluda Medical

Series D

Total Funding: $190M

SetPoint Medical

Series C

Total Funding: $300M

Onc.AI

Series A

Total Funding: $31M

Exo

Series B

Total Funding: $310M

CVRx

Series G

Total Funding: $160M

Work Experience

Action Potential Venture Capital

2014

  • Partner

    2014

    Investing in the next generation of Bioelectronic Medicines, Precision Diagnostics (AI), and Computational Biology. www.actionpotentialvc.com Board Member at Onc.AI, Exo Imaging, Saluda Medical, SetPoint Medical, Presidio Medical, and Cala Health.

Onc.AI

2022

  • Board Member

    2022

    Onc.AI is developing a multimodal AI/ML radiomics platform, to support oncologists in personalized therapeutic decision-making for patients across cancer types.

Exo Imaging, Inc.

2020

  • Board Member

    2020

Saluda Medical

2017

  • Board Member

    2017

Presidio Medical, Inc.

2018

  • Board Member

    2018

SetPoint Medical

2014

  • Board Member

    2014

Gradient Denervation Technologies

2020

  • Board Member

    2020

Neuspera Medical Inc.

2016

  • Board Observer

    2016

Cala Health

2016

  • Board Member

    2023

  • Board Observer

    2016 - 2023

Wu Tsai Neurosciences Institute

2018

  • Stanford Wu Tsai Neurosciences Institute: Translational Oversight Committee

    2018